Neurocrine Biosciences NBIX
NASDAQ NBIX
$155.40 -0.14 (-0.09%)
At close: Aug 20, 2026 · 11:01 AM UTC

Neurocrine Biosciences (NBIX) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Neurocrine Biosciences (NBIX) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn 14.04%
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 2.87%
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 8.71%
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -34.81%
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 14.78%
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn 36.74%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.19 Bn 7.53 Bn 397.90 Mn -86.97%

Historic Data

Download Data
DateValue
Jun 30, 2026 14.78%
Mar 31, 2026 66.11%
Dec 31, 2025 19.98%
Sep 30, 2025 45.15%
Jun 30, 2025 102.96%
Mar 31, 2025 -17.17%
Dec 31, 2024 152.63%
Sep 30, 2024 79.35%
Jun 30, 2024 15.40%
Mar 31, 2024 10.58%
Dec 31, 2023 -24.84%
Sep 30, 2023 51.00%
Jun 30, 2023 6.26%
Mar 31, 2023 -59.37%
Dec 31, 2022 37.82%
Sep 30, 2022 8.39%
Jun 30, 2022 -32.56%
Mar 31, 2022 28.79%
Dec 31, 2021 -33.68%
Sep 30, 2021 -23.76%